Mizuho Trust & Banking’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,579,678
Closed -$163M 15
2016
Q3
$163M Buy
2,579,678
+15,582
+0.6% +$1.01M 0.48% 44
2016
Q2
$159M Sell
2,564,096
-25,623
-1% -$1.56M 0.49% 45
2016
Q1
$148M Buy
2,589,719
+58,691
+2% +$3.27M 0.47% 47
2015
Q4
$151M Sell
2,531,028
-99,192
-4% -$5.71M 0.5% 44
2015
Q3
$143M Buy
2,630,220
+96,567
+4% +$6.29M 0.5% 43
2015
Q2
$170M Buy
2,533,653
+232,072
+10% +$15.2M 0.56% 38
2015
Q1
$135M Buy
2,301,581
+185,640
+9% +$11.2M 0.46% 51
2014
Q4
$138M Buy
2,115,941
+40,649
+2% +$2.56M 0.49% 44
2014
Q3
$120M Sell
2,075,292
-129,353
-6% -$7.18M 0.45% 44
2014
Q2
$124M Sell
2,204,645
-38,514
-2% -$2.02M 0.45% 46
2014
Q1
$115M Sell
2,243,159
-33,073
-1% -$1.67M 0.43% 49
2013
Q4
$116M Sell
2,276,232
-24,416
-1% -$1.2M 0.44% 48
2013
Q3
$95.1M Hold
2,300,648
0.4% 53
2013
Q2
$95.1M Buy
+2,300,648
New +$101M 0.4% 52

Other funds holding ABBV

Mizuho Trust & Banking's ABBV Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of AbbVie (ABBV) in Q4 2016, closing a stake of 2,579,678 shares — an estimated $163M sold.

Mizuho Trust & Banking first reported a position in ABBV in Q2 2013 and held it in 14 quarters. The position peaked at $170M in Q2 2015. 1,692 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining AbbVie position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 2,579,678 AbbVie shares in Q4 2016, an estimated $163M.
  • Mizuho Trust & Banking first reported a position in AbbVie in Q2 2013 and held it in 14 quarters.
  • Mizuho Trust & Banking's AbbVie position peaked at $170M in Q2 2015.
  • 1,692 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.